(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALICOSINUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALICOSINUM

ST13

US500000097253156

Class

5

Filing

97253156

Registration

6991448

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

02/28/2023

Trademark type

Word

Nice classes

5

Filing date

02/04/2022

Registration date

02/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/28/2023

Last transaction

02/28/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

09/23/2022

First use in commerce

09/23/2022

Drawing code

4

Owner type

03

Owner location

Surrey BC, CA

Examiner

DUFFIN, GRACE

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Pharmaris Canada Inc.

Representatives

Nyall Engfield

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Homeopathic pharmaceuticals for use in the treatment of flu and flu-like symptomsbody achesheadachesfeversore throattiredness and chills

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/28/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/13/2022

PUBO

PUBLISHED FOR OPPOSITION

12/13/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/23/2022

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

11/10/2022

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

11/04/2022

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

10/29/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/28/2022

IUAA

USE AMENDMENT ACCEPTED

10/28/2022

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

10/10/2022

IUAF

USE AMENDMENT FILED

10/10/2022

EAAU

TEAS AMENDMENT OF USE RECEIVED

10/08/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/03/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/25/2022

GNSL

LETTER OF SUSPENSION E-MAILED

09/25/2022

CNSL

SUSPENSION LETTER WRITTEN

09/25/2022

DOCK

ASSIGNED TO EXAMINER

09/25/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/09/2022

NWAP

NEW APPLICATION ENTERED

02/08/2022

Continuous trademark protection

Get notified about every new filing that threatens ALICOSINUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.